|9328T||1 Kit (9 x 20 microliters)||
|c-Fos Antibody 4384||20 µl||
||H M R||62||Rabbit|
|c-Abl Antibody 2862||20 µl||
||H M R||135 (c-Abl); 210 (Bcr-Abl)||Rabbit|
|c-Jun (60A8) Rabbit mAb 9165||20 µl||
||H M R Mk||43, 48||Rabbit IgG|
|c-Kit (D13A2) XP® Rabbit mAb 3074||20 µl||
||H M||120 and 145||Rabbit|
|c-Myc (D84C12) Rabbit mAb 5605||20 µl||
||H M R||57-65||Rabbit IgG|
|c-Raf Antibody 9422||20 µl||
||H M R Mk||65 to 75||Rabbit|
|Ras (27H5) Rabbit mAb 3339||20 µl||
||H M R Mk Dm||21||Rabbit IgG|
|Src (32G6) Rabbit mAb 2123||20 µl||
||H M R Mk||60||Rabbit IgG|
|Anti-rabbit IgG, HRP-linked Antibody 7074||100 µl||
|c-Rel (D4Y6M) Rabbit mAb 12707||20 µl||
||H M R||68-78||Rabbit IgG|
Polyclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues near the carboxy terminus of human c-Rel, residues near the carboxy-terminus of human c-Fos, and corresponding to the sequence close to the carboxy-terminus of human c-Abl. Antibodies are purified by protein A and peptide affinity chromatography. Monoclonal antibody is produced by immunizing animals with a recombinant fusion protein corresponding to residues 1-110 of human Src, residues near the amino terminus of human K-Ras, from the amino-terminal sequence of human c-Jun, residues near the amino terminus of c-Myc and corresponding to the residues surrounding Tyr703 of human c-Kit.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.